Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belinostat in Recurrent/Refractory T-Cell Lymphomas
NCT00274651Phase 2Terminated
- Sponsor
- Valerio Therapeutics
- Start
- Jan 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of belinostat in cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), sponsored by Valerio Therapeutics. Started Jan 2006; status: terminated.
02
Drugs
belinostat
03
Conditions
cutaneous T-cell lymphoma (CTCL)peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00274651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274651.